Rion Co., Ltd. (TYO:6823)
Japan · Delayed Price · Currency is JPY 2,654.00
-46.00 (-1.70%)
Aug 14, 2025, 3:30 PM JST
Rion Co., Ltd. Revenue
Rion Co., Ltd. had revenue of 6.63B JPY in the quarter ending June 30, 2025, with 4.31% growth. This brings the company's revenue in the last twelve months to 28.15B, up 7.99% year-over-year. In the fiscal year ending March 31, 2025, Rion Co., Ltd. had annual revenue of 27.88B with 8.36% growth.
Revenue (ttm)
28.15B
Revenue Growth
+7.99%
P/S Ratio
1.18
Revenue / Employee
27.90M
Employees
1,009
Market Cap
33.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27.88B | 2.15B | 8.36% |
| Mar 31, 2024 | 25.73B | 1.86B | 7.78% |
| Mar 31, 2023 | 23.87B | 1.23B | 5.45% |
| Mar 31, 2022 | 22.64B | 2.17B | 10.60% |
| Mar 31, 2021 | 20.47B | -999.00M | -4.65% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |